StockData
Helus Pharma Inc. logo

Helus Pharma Inc. (HELP) stock

HELPNasdaqPharmaceutical PreparationsFiscal year ends March 31
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 40-F on Jun 29, 2026Score 0/30
$8.86−0.53 (-5.64%)

Close on Nov 12, 2026Market cap $457.46MP/E –Yield –

Helus Pharma total assets

Total assets on the balance sheet at the end of each period.

Helus Pharma's total assets was C$258.62M at Mar 31, 2025. For fiscal 2025 it was C$258.62M, down 14.4% from the year before. The highest annual figure on record is C$302.02M in fiscal 2024.

Annual total assets

PeriodPeriod endValueChange
FY2025Mar 31, 2025C$258.62M-14.4%
FY2024Mar 31, 2024C$302.02M+460.4%
FY2023Mar 31, 2023C$53.90M-35.9%
FY2022Mar 31, 2022C$84.06M-8.7%
FY2021Mar 31, 2021C$92.11M–

Quarterly total assets

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2025CQ1 2025Mar 31, 2025C$258.62M+180.8%
Q4 FY2024CQ1 2024Mar 31, 2024C$302.02M–
Q4 FY2023CQ1 2023Mar 31, 2023C$53.90M–
Q4 FY2022CQ1 2022Mar 31, 2022C$84.06M–
Q4 FY2021CQ1 2021Mar 31, 2021C$92.11M–

More Helus Pharma figures

See a number that looks wrong?